Two great stories of translation science leading to beneficial drugs in terrible diseases of the heart and the Sisyphean task of predicting the need for pacing after TAVI are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I Sotatercept
- HYPERION Trial https://www.nejm.org/doi/10.1056/NEJMoa2508170
- ZENITH Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2415160
- Evidence report on treatment for PAH https://icer.org/news-insights/press-releases/icer-publishes-final-evidence-report-on-treatment-for-pulmonary-arterial-hypertension/
- PAH Sotatercept Editorial https://www.nejm.org/doi/full/10.1056/NEJMe2503944
II Acoramidis and ATTR Cardiomyopathy
- ATTRIBUTE-CM Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2305434?logout=true
- ATTRIBUTE-CM Analysis - Substudy https://www.jacc.org/doi/10.1016/j.jacc.2025.09.013
- Tafamadis Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1805689
III Pacing After TAVI
- Prophylactic pacemaker after TAVI https://www.jacc.org/doi/10.1016/j.jacep.2025.07.028
- PROMOTE study https://doi.org/10.1016/j.hrthm.2024.12.019
- Evaluation of ESC criteria on RBBB patients undergoing TAVI https://doi.org/10.1016/j.hrthm.2024.11.030
- Editorial on Heart Rhythm journal papers https://www.heartrhythmjournal.com/article/S1547-5271(25)00114-6/abstract
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net
